Cargando…
Dysregulation of the endothelin pathway in lymphangioleiomyomatosis with no direct effect on cell proliferation and migration
LAM is a rare low-grade metastasizing lung neoplasm. Inhibitors of mTOR improve clinical outcome of LAM patients by preventing loss of lung function. Nevertheless, other cell targets may be of interest for drug development. Therefore, we explored the potential role of EDN1 (endothelin) in LAM. We re...
Autores principales: | Chebib, Nader, Archer, Fabienne, Bobet-Erny, Alexandra, Leroux, Caroline, Cottin, Vincent |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6168484/ https://www.ncbi.nlm.nih.gov/pubmed/30279475 http://dx.doi.org/10.1038/s41598-018-32795-3 |
Ejemplares similares
-
Blocked expression of key genes of the angiogenic pathway in JSRV-induced pulmonary adenocarcinomas
por: Gomes, Maryline, et al.
Publicado: (2017) -
State of the art on lung organoids in mammals
por: Archer, Fabienne, et al.
Publicado: (2021) -
Air travel and incidence of pneumothorax in lymphangioleiomyomatosis
por: Gonano, Cynthia, et al.
Publicado: (2018) -
Dysregulated lipid metabolism in lymphangioleiomyomatosis pathogenesis as a paradigm of chronic lung diseases
por: Bernardelli, Clara, et al.
Publicado: (2023) -
Understanding the priorities for women diagnosed with lymphangioleiomyomatosis: a patient perspective
por: Bassi, Iris, et al.
Publicado: (2016)